Drug Treatment of Obesity: From Bench to Bedside

Obesity is a complex metabolic and behavioural disorder associated with increased health risk, including coronary artery disease, congestive heart failure and sudden cardiac death. Effective prevention and treatment strategies for obesity are needed. This unmet need for efficient and safe antiobesity medication resulted in many new therapies at various stages of development. Obesity has become one of the most intensively studied diseases because of the availability of suitable animal and cell culture models of adipocyte differentiation and appetite regulation. obstructive and certain types of cancer.

• Publication year

  2018

• Venue

  Drug Discovery

• Publication date

  2018-02-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.5772/INTECHOPEN.73559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Stimulants for the Control of Hedonic Appetite

  2016cited by this paper
• Chronic endothelin‐1 infusion causes adipocyte hyperplasia in rats

  2016cited by this paper
• Evolution of pharmacological obesity treatments: focus on adverse side‐effect profiles

  2016cited by this paper
• Resveratrol exerts anti-obesity effects in high-fat diet obese mice and displays differential dosage effects on cytotoxicity, differentiation, and lipolysis in 3T3-L1 cells.

  2016cited by this paper
• Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.

  2016cited by this paper
• Cell Models and Their Application for Studying Adipogenic Differentiation in Relation to Obesity: A Review

  2016cited by this paper
• Bisdemethoxycurcumin Inhibits Adipogenesis in 3T3-L1 Preadipocytes and Suppresses Obesity in High-Fat Diet-Fed C57BL/6 Mice.

  2016cited by this paper
• Creatine Inhibits Adipogenesis by Downregulating Insulin-Induced Activation of the Phosphatidylinositol 3-Kinase Signaling Pathway

  2015cited by this paper
• Islet α cells and glucagon—critical regulators of energy homeostasis

  2015cited by this paper
• Biologic Responses to Weight Loss and Weight Regain: Report From an American Diabetes Association Research Symposium

  2015cited by this paper
• Cidec promotes the differentiation of human adipocytes by degradation of AMPKα through ubiquitin-proteasome pathway.

  2015cited by this paper
• Quercetin prevents adipogenesis by regulation of transcriptional factors and lipases in OP9 cells.

  2015cited by this paper
• Cineromycin B isolated from Streptomyces cinerochromogenes inhibits adipocyte differentiation of 3T3-L1 cells via Krüppel-like factors 2 and 3.

  2015cited by this paper
• European Guidelines for Obesity Management in Adults

  2015cited by this paper
• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

  2015cited by this paper
• AHA / ACC / TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines and The Obesity Society Endorsed

  2014cited by this paper
• Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes

  2014cited by this paper
• Low abdominal subcutaneous preadipocyte adipogenesis is associated with visceral obesity, visceral adipocyte hypertrophy, and a dysmetabolic state

  2014cited by this paper
• Optimal protocol for the differentiation and metabolic analysis of human adipose stromal cells.

  2014cited by this paper
• Improved methodologies for the study of adipose biology: insights gained and opportunities ahead

  2014cited by this paper
• Phloretin promotes adipocyte differentiation in vitro and improves glucose homeostasis in vivo.

  2014cited by this paper
• 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.

  2014cited by this paper
• Peripheral targets in obesity treatment: a comprehensive update

  2014cited by this paper
• Ascorbic acid is a dose-dependent inhibitor of adipocyte differentiation, probably by reducing cAMP pool

  2014cited by this paper
• MicroRNA-199a-5p Affects Porcine Preadipocyte Proliferation and Differentiation

  2014influential reference
• Metabolic regulation by protein tyrosine phosphatases

  2014cited by this paper
• Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity

  2014cited by this paper
• Prevalence of obesity in the United States.

  2014cited by this paper
• The future role of gut hormones in the treatment of obesity

  2014cited by this paper
• miR-125a inhibits porcine preadipocytes differentiation by targeting ERRα

  2014cited by this paper
• Tributyltin affects adipogenic cell fate commitment in mesenchymal stem cells by a PPARγ independent mechanism.

  2014cited by this paper
• A review of late-stage CNS drug candidates for the treatment of obesity

  2013cited by this paper
• The role of kidney in glucose homeostasis – SGLT2 inhibitors, a new approach in diabetes treatment

  2013cited by this paper
• Emerging combinatorial hormone therapies for the treatment of obesity and T2DM

  2013cited by this paper
• Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

  2013cited by this paper
• MiRNA-181a Regulates Adipogenesis by Targeting Tumor Necrosis Factor-α (TNF-α) in the Porcine Model

  2013cited by this paper
• Antiobesity Pharmacotherapy: New Drugs and Emerging Targets

  2013cited by this paper
• Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion

  2013cited by this paper
• 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults

  2013cited by this paper
• Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice

  2013influential reference
• Study of lactoferrin gene expression in human and mouse adipose tissue, human preadipocytes and mouse 3T3-L1 fibroblasts. Association with adipogenic and inflammatory markers.

  2013cited by this paper
• Targets for Medical Therapy in Obesity

  2012cited by this paper
• A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers

  2012cited by this paper
• Restoration of leptin responsiveness in diet‐induced obese mice using an optimized leptin analog in combination with exendin‐4 or FGF21

  2012cited by this paper
• Obesity, a health burden of a global nature

  2012cited by this paper
• Integrative and Translational Physiology : Integrative Aspects of Energy Homeostasis and Metabolic Diseases Potential clinical translation of juvenile rodent inactivity models to study the onset of childhood obesity

  2012cited by this paper
• Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study

  2012cited by this paper
• Adipose tissue stem cells meet preadipocyte commitment: going back to the future[S]

  2012cited by this paper
• Prevalence of obesity in the United States, 2009-2010.

  2012cited by this paper
• Overview of Animal Models of Obesity

  2012cited by this paper
• Differences in metabolomic profiles of male db/db and s/s, leptin receptor mutant mice.

  2012cited by this paper
• Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist.

  2012cited by this paper
• Consumption of a high-fat diet induces central insulin resistance independent of adiposity.

  2011cited by this paper
• A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.

  2011cited by this paper
• Adipokines in inflammation and metabolic disease

  2011cited by this paper
• Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion.

  2011cited by this paper
• Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)

  2011cited by this paper
• Topiramate-induced weight loss: a review.

  2011cited by this paper
• Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation

  2011cited by this paper
• Targeting thermogenesis and related pathways in anti-obesity drug discovery.

  2011cited by this paper
• Cell line models for differentiation: preadipocytes and adipocytes

  2010cited by this paper
• Lipid homeostasis, lipotoxicity and the metabolic syndrome.

  2010cited by this paper
• Chronic Consumption of a High-Fat Diet during Pregnancy Causes Perturbations in the Serotonergic System and Increased Anxiety-Like Behavior in Nonhuman Primate Offspring

  2010cited by this paper
• Annual medical spending attributable to obesity: payer-and service-specific estimates.

  2009cited by this paper
• New developments in adipogenesis.

  2009cited by this paper
• Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism

  2008cited by this paper
• Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.

  2008cited by this paper
• SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis

  2008cited by this paper
• AMPK: a key regulator of energy balance in the single cell and the whole organism

  2008cited by this paper
• Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization

  2008cited by this paper
• The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS

  2008cited by this paper
• Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor.

  2008cited by this paper
• The influence of thiazolidinediones on adipogenesis in vitro and in vivo: potential modifiers of intramuscular adipose tissue deposition in meat animals.

  2008cited by this paper
• General and abdominal adiposity and risk of death in Europe.

  2008cited by this paper
• Reduction of Visceral Fat Is Associated With Decrease in the Number of Metabolic Risk Factors in Japanese Men

  2008cited by this paper
• Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients

  2007cited by this paper
• RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27

  2007cited by this paper
• Pancreatic lipase inhibitors from natural sources: unexplored potential.

  2007cited by this paper
• Differential accessibility of circulating leptin to individual hypothalamic sites.

  2007cited by this paper
• OP9 mouse stromal cells rapidly differentiate into adipocytes: characterization of a useful new model of adipogenesis Published, JLR Papers in Press, November 30, 2005

  2006cited by this paper
• Differential uptake of molecules from the circulation and CSF reveals regional and cellular specialisation in CNS detection of homeostatic signals

  2006cited by this paper
• Adipocyte differentiation from the inside out

  2006cited by this paper
• Noradrenergic and dopaminergic effects of (+)‐amphetamine‐like stimulants in the baboon Papio anubis

  2005cited by this paper
• Formation of Projection Pathways from the Arcuate Nucleus of the Hypothalamus to Hypothalamic Regions Implicated in the Neural Control of Feeding Behavior in Mice

  2004cited by this paper
• Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice.

  2004cited by this paper
• Novel adipocyte lines from brown fat: a model system for the study of differentiation, energy metabolism, and insulin action.

  2002cited by this paper
• A role for ghrelin in the central regulation of feeding

  2001cited by this paper
• The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

  2001cited by this paper
• Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.

  2001cited by this paper
• Adipocyte Differentiation: From Fibroblast to Endocrine Cell

  2001cited by this paper
• Adipocyte differentiation and gene expression.

  2000cited by this paper
• The Biosynthesis of Hepatic Cholesterol Esters and Triglycerides Is Impaired in Mice with a Disruption of the Gene for Stearoyl-CoA Desaturase 1*

  2000cited by this paper
• Neurochemical Characterization of Hypothalamic Cocaine—Amphetamine-Regulated Transcript Neurons

  1999influential reference
• Knockout Corner: Neurobehavioural consequences of a serotonin 5-HT(2C) receptor gene mutation.

  1999cited by this paper
• Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice.

  1998cited by this paper
• Topiramate: a review of preclinical, pharmacokinetic, and clinical data.

  1997cited by this paper
• Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

  1997cited by this paper
• A role for glucagon-like peptide-1 in the central regulation of feeding

  1996cited by this paper
• Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur.

  1995cited by this paper
• Targeted Disruption of the β3-Adrenergic Receptor Gene *

  1995cited by this paper

• Long-Term Follow-Up of a Randomized Controlled Trial to Reduce Excessive Weight Gain in Infancy: Protocol for the Prevention of Overweight in Infancy (POI) Follow-Up Study at 11 Years

  2020cites this paper
• Obesity Diabetes and Ketoacidosis in Elderly

  2019cites this paper